Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Mary Erickson"'
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0300809 (2024)
The nuclear farnesoid X receptor (FXR), a master regulator of bile acid and metabolic homeostasis, is a key target for treatment of nonalcoholic steatohepatitis (NASH). This study compared efficacy of FXR agonists obeticholic acid (OCA) and INT-787 b
Externí odkaz:
https://doaj.org/article/32914ff5801543ee9abbd0125ee55712
Autor:
Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Christina Christoffersen, Michael Feigh, Niels Vrang, Jonathan David Roth, Mary Erickson, Luciano Adorini, Jacob Jelsing
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Compounds in clinical development for nonalcoholic steatohepatitis (NASH) improve liver histopathology in diet-induced obese mouse models of biopsy-confirmed NASH. Since the biopsy section used for histopathological evaluation rep
Externí odkaz:
https://doaj.org/article/e44142f92aa546f5bc09dfe64650bb25
Autor:
Rotonya M. Carr, Yun Li, Lillian Chau, Elliot S. Friedman, Jung-Jin Lee, Luciano Adorini, Mary Erickson, Luna Zaru, Reshma Shringarpure, Leigh MacConell, Kyle Bittinger, Hongzhe Li, Gary D. Wu
Publikováno v:
Hepatology.
Autor:
Mary Erickson
Publikováno v:
Historical Journal of Film, Radio and Television. 42:592-611
In 1953, Bellingham’s KVOS-TV aired its first broadcast—Queen Elizabeth II’s coronation—to audiences in northwest Washington State and southwest British Columbia. KVOS was the second television sta...
Publikováno v:
Brain Behav Immun
Environmental enrichment (EE) has been successfully implemented in human rehabilitation settings. However, the mechanisms underlying its success are not understood. Incorporating components of EE protocols into our animal models allows for the explor
Publikováno v:
In Clinical Simulation in Nursing August 2013 9(8):e305-e310
Autor:
Alan F. Hofmann, Mary Erickson, Kristoffer Kjærgaard, Susanne Keiding, David Shapiro, Michael Sørensen, Anna C. Schacht, Ole Lajord Munk, Jacob Horsager, Kim Frisch
Publikováno v:
Kjærgaard, K, Frisch, K, Sørensen, M, Munk, O L, Hofmann, A F, Horsager, J, Schacht, A C, Erickson, M, Shapiro, D A & Keiding, S 2021, ' Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis ', Journal of Hepatology, vol. 74, no. 1, pp. 58-65 . https://doi.org/10.1016/j.jhep.2020.07.028
Background & Aims: Obeticholic acid (OCA) is an agonist of the nuclear bile acid receptor farnesoid X receptor, which regulates hepatic bile acid metabolism. We tested whether OCA treatment would influence hepatic transport of conjugated bile acids i
Publikováno v:
Dev Psychobiol
The mechanisms that link maternal immune activation (MIA) with the onset of neurodevelopmental disorders remain largely unclear. Accelerated puberty is also associated with a heightened risk for psychopathology in later life but there is a dearth of
Autor:
Megel, Mary Erickson, Black, Joyce, Clark, Lissa, Carstens, Patricia, Jenkins, Lindsay D., Promes, Jennifer, Snelling, Melissa, Zander, Katie E., Bremer, Alicia, Goodman, Tara
Publikováno v:
In Clinical Simulation in Nursing November 2012 8(9):e419-e428
Autor:
Michael Feigh, Jacob Jelsing, Sanne Skovgård Veidal, Luciano Adorini, Christina Christoffersen, Jonathan D. Roth, Mary Erickson, Niels Vrang, Maria Kristiansen
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-11 (2019)
Kristiansen, M N B, Veidal, S S, Christoffersen, C, Feigh, M, Vrang, N, Roth, J D, Erickson, M, Adorini, L & Jelsing, J 2019, ' Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH ', B M C Gastroenterology, vol. 19, no. 1, 228 . https://doi.org/10.1186/s12876-019-1149-z
BMC Gastroenterology
Kristiansen, M N B, Veidal, S S, Christoffersen, C, Feigh, M, Vrang, N, Roth, J D, Erickson, M, Adorini, L & Jelsing, J 2019, ' Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH ', B M C Gastroenterology, vol. 19, no. 1, 228 . https://doi.org/10.1186/s12876-019-1149-z
BMC Gastroenterology
Background Compounds in clinical development for nonalcoholic steatohepatitis (NASH) improve liver histopathology in diet-induced obese mouse models of biopsy-confirmed NASH. Since the biopsy section used for histopathological evaluation represents o